Debra L. Palazzi, M.D, M.Ed.
Dr. Palazzi's research interests include antimicrobial stewardship and diagnostic stewardship. She participates in the Sharing Reports for Pediatric Stewardship (SHARPS) Collaborative and the Agency for Healthcare Research and Quality study on de-implementation of unnecessary surgical antibiotic prophylaxis in children.
Claire E. Bocchini, M.D.
Dr. Bocchini’s research interests include the treatment and prevention of infectious diseases in immunocompromised children, including children who undergo hematopoietic stem cell and solid organ transplants. She has also led projects assessing and addressing vaccine hesitancy, especially in families of immunocompromised children. Finally, Dr. Bocchini conducts research aimed at ameliorating nonmedical drivers of health in families of children who are immunocompromised or have other chronic medical conditions.
Judith R. Campbell, M.D.
Dr. Campbell’s primary interests are in the epidemiology and prevention of healthcare associated infections. Specifically, she investigates risk factors for and prevention of healthcare-associated infections in high-risk patients, such as premature neonates, immunocompromised hosts, and those with complex medical conditions. She is especially interested in multi-disciplinary collaboration projects across several subspecialties to implement evidence-based quality improvement initiatives.
Gail J. Demmler-Harrison, M.D.
Dr. Demmler-Harrison’s research focuses on congenital and neonatal infections. She conducts studies on the epidemiology, diagnosis, treatment, and neurodevelopmental, ocular, and audiologic outcomes of children born with congenital cytomegalovirus (CMV) infection and disease, and the impact of this congenital infection on personal and family life, society, and the health care system. She also is involved in research and development studies for rapid diagnosis of congenital and neonatal infections, and newborn screening for congenital CMV. She also participates in multicenter clinical trials evaluating antiviral treatment of congenital CMV.